Carbohydrate-restricted diet in inflammatory bowel disease

Phase 1

• Conditions: Inflammatory bowel disease (ulcerative colitis).; K51; Ulcerative

• Registration Number: IRCT20170202032367N7
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Age above 20 and less than 60 years
Patients with mild to moderate ulcerative colitis
Willingness to participate in the study

Exclusion Criteria

Changing the type of medicine used and its dosage during the last month
Having other intestinal diseases (malignancies, infectious diseases)
Suffering from other inflammatory diseases and kidney diseases and diabetes
Pregnancy or breastfeeding
Use of antibiotics, or use of pre- or probiotic products, or use of multivitamin and mineral supplements, or use of anti-inflammatory supplements such as w3 and curcumin during the intervention and in the one-month period before the intervention.
Smoking and drug use
History of hospitalization during the last three months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
utritional status. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Anthropometric measurements including weight, height, and BMI calculation will be done and will be included in the questionnaire.;Inflammation. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Eliza kit.;Quality of Life. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Inflammatory bowel disease questionnaire.

Secondary Outcome Measures

Name	Time	Method
Complete blood cell count. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Auto Analyzer device.